1. Global prevalente and incidence of curable STis. World Health Organization, 2001 (WHO/CDC/CDR/EDC/2001.10).
2. Mayand P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Trans Inf 2004; 80: 174–82.
3. Hueston WJ, Lenhart JG. A decision analysis to guige antibiotis selection for Chlamydia infection during pregnancy. Arch Fam Med 1997; 6: 551–5.
4. Centers for disease and prevention. Sexually transmitted disease surveillance 2003 supplement. Atlanta, GA; CDC, 2004.
5. Advanced Fertility Center of Chicago. http://www.advancedfertility.com/ectopic.htm[accessed 9 May 2007].
6. Woman at the Rise of the 21st Centry: Gynecological and Reproductine issues in Health and Diseases. Conference proceadings. Athens, Greece,Vovember 18–21, 1998. Ann NY Acad Sci 2000; 900: 1–446.
7. Grossman JH, Rivein ME, Morrison JC. Diagnosis of Chlamydial infection in pregnant women using the Testpack Chlamydia diagnostic kit. Obstet Gynecol 1991; 77: 801–3.
8. Andrews WN, Goldenferd RL, Mercer B et al. The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183: 662–8 (Abstract).
9. Fiest A, Sydier T, Gebbers SS et al. No association of Chlamydia with abortion. J Soc Med 1999; 92 (5): 237–8.
10. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
11. Centers for Disease Control and Prevention. Sexyally Transmitted Diseases Treatment Quidelines-2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1–80.
712. Национальные стандарты в здравоохранении: перспективы разработки и внедрения. Врач 2008. Спец. вып: 2–60.
13. Стандарты медицинской помощи больным урогенитальными инфекциями. Врач. 2009; 1: 36–67.
14. Клинические рекомендации. Российское общество дерматовенерологов. Дерматовенерология. Под ред. А.А.Кубановой. М.: ДЭКС-Пресс, 2008.
15. Клинические рекомендации. Акушерство и гинекология. Под ред. В.Н.Серова, Г.Т.Сухих. 3-е изд. М.: ГОЭТАР-Медиа, 2009.
16. Рациональная фармакотерапия в акушерстве, гинекологии и неонатологии. Под ред. В.Н.Серова, Г.Т.Сухих. М.: Литтерра, 2010.
17. Harris RP, Hefland M, Woolf SH et al. Current methods of the us preventive services task force: a revin of the process. Am J Prev Med 2001; 20 (suppl.): 21–35.
18. Andrade SE, Gurwitz JM, Davis RL et al. Prescription drug use in pregnany. Am J Obstet Gynecol 2004; 191: 398–407.
19. Guidelines for the management of sexually transmitted infections, World Health Organization, 2003.
20. Европейские стандарты диагностики и лечения заболеваний, передаваемых половым путем. М.: Медицинская литература, 2003.
21. Center for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases. MMWR 2006.
22. http://www.iusti.org Draft European (IUSTI/WHO) for the management of Chlamydia trachomatis infections.
23. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A case-control teratological study of spiramycin, roxitromycin, oleandomycin and josamycin. Acta Gynecol Scand 2000; 79: 234–7.
24. Solitz-Szots J, Schneider S, Niebauer B et al. [Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients]. Z Hautkr 1989; 64: 129–31.
25. Седых Н.Н. Этические гарантии доказанности клинических испытаний. Биоэтика. 2008; 1: 16–21.
26. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–5.
27. McCormack WM, George H, Donner A. Hepatotoxicity of erythromycin estolate during pregnancy. AntiMicrob Agents Chemother 1977; 12: 630–5.
28. Kallen BAJ, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol 2005; 20: 209–14.
29. Volberg WA, Koci BJ, Su W et al. Blockade of human cardias potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320–7.
30. Dylewski J, Clecner B, Dubois J et al. Comparison of spiramycin and doxycycline for treatment of Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 1993; 37 (6): 1373–4.
31. Fedele L, Acaia B, Marchini M et al. Treatment of Chlamydia trachomatis endometritis with josamycin. J Chemother 1989; 1 (4 Suppl.): 911–2.
32. Решетников О.В., Хрянин А.А. Макролиды в лечении хламидийной инфекции у беременных (эффективность, безопасность, экономичность). Рус. мед. журн. 2008; 16: 23–7.
33. Khrianin AA, Reshetnikov OV. Is it safe to use josamycin in the obstetrics practice in Russia? Antibiot Khimioter 2007; 52: 32–6.
34. Charles P, Stumpf P, Buffet P et al. Two unusual glandular presentations of tick-borne tularemia. Med Mal Infect 2008; 8: 159–61.
35. Юрьев С.Ю., Евтушенко И.Д., Огородова Л.М. Определение концентрации азитромицина в хориальной ткани в I триместре беременности. Антибиот. и химиотер. 2004; 49: 10–2.
36. Ramsey PS, Vaules MB, Vasdev GM et al. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 2003; 188: 714–8.
37. Jacobson GF, Autry AM, Kirby RS et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001; 184: 1352–4.
38. Edwards MS, Newman RB, Carter SG et al. Randomized clinical trial of azithromycin vs erythromycin for the treatment of Chlamydia cervicitis in pregnancy. Infect Dis Obstet Cynecol 1997; 4: 333–7.
39. Sarkar M, Woodland CC, Koren G, Einarson ARN. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.
40. Brockleburst P, Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy (Cocbrane Review). In: The Cocbrane Library, Issue 3, 2004. Chicbester, UK: John Wiley & Sons, Ltd.
41. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
42. Kacmar J, Cheh E, Montagno A, Peipert JF. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001; 9: 197–202.
43. Gunter ME, Adair CD, Ernest JM, McElroy G. Azithromycin powder versus erythromycin in the treatment of chlamydial cervicitis in pregnancy. Infect Dis Obstet Gynecol 1996; 4: 53.
44. Adair CD, Gunter M, Stovall TG et al. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998; 91: 165–8.

________________________________________________

1. Global prevalente and incidence of curable STis. World Health Organization, 2001 (WHO/CDC/CDR/EDC/2001.10).
2. Mayand P, Mabey D. Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Sex Trans Inf 2004; 80: 174–82.
3. Hueston WJ, Lenhart JG. A decision analysis to guige antibiotis selection for Chlamydia infection during pregnancy. Arch Fam Med 1997; 6: 551–5.
4. Centers for disease and prevention. Sexually transmitted disease surveillance 2003 supplement. Atlanta, GA; CDC, 2004.
5. Advanced Fertility Center of Chicago. http://www.advancedfertility.com/ectopic.htm[accessed 9 May 2007].
6. Woman at the Rise of the 21st Centry: Gynecological and Reproductine issues in Health and Diseases. Conference proceadings. Athens, Greece,Vovember 18–21, 1998. Ann NY Acad Sci 2000; 900: 1–446.
7. Grossman JH, Rivein ME, Morrison JC. Diagnosis of Chlamydial infection in pregnant women using the Testpack Chlamydia diagnostic kit. Obstet Gynecol 1991; 77: 801–3.
8. Andrews WN, Goldenferd RL, Mercer B et al. The Preterm Prediction Study: association of second-trimester genitourinary Chlamydia infection with subsequent spontaneous preterm birth. Am J Obstet Gynecol 2000; 183: 662–8 (Abstract).
9. Fiest A, Sydier T, Gebbers SS et al. No association of Chlamydia with abortion. J Soc Med 1999; 92 (5): 237–8.
10. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
11. Centers for Disease Control and Prevention. Sexyally Transmitted Diseases Treatment Quidelines-2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1–80.
712. Национальные стандарты в здравоохранении: перспективы разработки и внедрения. Врач 2008. Спец. вып: 2–60.
13. Стандарты медицинской помощи больным урогенитальными инфекциями. Врач. 2009; 1: 36–67.
14. Клинические рекомендации. Российское общество дерматовенерологов. Дерматовенерология. Под ред. А.А.Кубановой. М.: ДЭКС-Пресс, 2008.
15. Клинические рекомендации. Акушерство и гинекология. Под ред. В.Н.Серова, Г.Т.Сухих. 3-е изд. М.: ГОЭТАР-Медиа, 2009.
16. Рациональная фармакотерапия в акушерстве, гинекологии и неонатологии. Под ред. В.Н.Серова, Г.Т.Сухих. М.: Литтерра, 2010.
17. Harris RP, Hefland M, Woolf SH et al. Current methods of the us preventive services task force: a revin of the process. Am J Prev Med 2001; 20 (suppl.): 21–35.
18. Andrade SE, Gurwitz JM, Davis RL et al. Prescription drug use in pregnany. Am J Obstet Gynecol 2004; 191: 398–407.
19. Guidelines for the management of sexually transmitted infections, World Health Organization, 2003.
20. Европейские стандарты диагностики и лечения заболеваний, передаваемых половым путем. М.: Медицинская литература, 2003.
21. Center for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases. MMWR 2006.
22. http://www.iusti.org Draft European (IUSTI/WHO) for the management of Chlamydia trachomatis infections.
23. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A case-control teratological study of spiramycin, roxitromycin, oleandomycin and josamycin. Acta Gynecol Scand 2000; 79: 234–7.
24. Solitz-Szots J, Schneider S, Niebauer B et al. [Significance of the dose of josamycin in the treatment of chlamydia infected pregnant patients]. Z Hautkr 1989; 64: 129–31.
25. Седых Н.Н. Этические гарантии доказанности клинических испытаний. Биоэтика. 2008; 1: 16–21.
26. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–5.
27. McCormack WM, George H, Donner A. Hepatotoxicity of erythromycin estolate during pregnancy. AntiMicrob Agents Chemother 1977; 12: 630–5.
28. Kallen BAJ, Otterblad Olausson P, Danielsson BR. Is erythromycin therapy teratogenic in humans? Reprod Toxicol 2005; 20: 209–14.
29. Volberg WA, Koci BJ, Su W et al. Blockade of human cardias potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320–7.
30. Dylewski J, Clecner B, Dubois J et al. Comparison of spiramycin and doxycycline for treatment of Chlamydia trachomatis genital infections. Antimicrob Agents Chemother 1993; 37 (6): 1373–4.
31. Fedele L, Acaia B, Marchini M et al. Treatment of Chlamydia trachomatis endometritis with josamycin. J Chemother 1989; 1 (4 Suppl.): 911–2.
32. Решетников О.В., Хрянин А.А. Макролиды в лечении хламидийной инфекции у беременных (эффективность, безопасность, экономичность). Рус. мед. журн. 2008; 16: 23–7.
33. Khrianin AA, Reshetnikov OV. Is it safe to use josamycin in the obstetrics practice in Russia? Antibiot Khimioter 2007; 52: 32–6.
34. Charles P, Stumpf P, Buffet P et al. Two unusual glandular presentations of tick-borne tularemia. Med Mal Infect 2008; 8: 159–61.
35. Юрьев С.Ю., Евтушенко И.Д., Огородова Л.М. Определение концентрации азитромицина в хориальной ткани в I триместре беременности. Антибиот. и химиотер. 2004; 49: 10–2.
36. Ramsey PS, Vaules MB, Vasdev GM et al. Maternal and transplacental pharmacokinetics of azithromycin. Am J Obstet Gynecol 2003; 188: 714–8.
37. Jacobson GF, Autry AM, Kirby RS et al. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001; 184: 1352–4.
38. Edwards MS, Newman RB, Carter SG et al. Randomized clinical trial of azithromycin vs erythromycin for the treatment of Chlamydia cervicitis in pregnancy. Infect Dis Obstet Cynecol 1997; 4: 333–7.
39. Sarkar M, Woodland CC, Koren G, Einarson ARN. Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 2006; 6: 18.
40. Brockleburst P, Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy (Cocbrane Review). In: The Cocbrane Library, Issue 3, 2004. Chicbester, UK: John Wiley & Sons, Ltd.
41. Miller JM, Martin DH. Treatment of Chlamydia trachomatis infections in pregnant women. Drugs 2000; 60 (3): 597–605.
42. Kacmar J, Cheh E, Montagno A, Peipert JF. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001; 9: 197–202.
43. Gunter ME, Adair CD, Ernest JM, McElroy G. Azithromycin powder versus erythromycin in the treatment of chlamydial cervicitis in pregnancy. Infect Dis Obstet Gynecol 1996; 4: 53.
44. Adair CD, Gunter M, Stovall TG et al. Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998; 91: 165–8.

В.И.Кисина

Первый МГМУ им. И.М.Сеченова (ректор – член-кор. РАМН, проф., П.В.Глыбочко)